Mcneil And Argus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.10 M
- Paid Up Capital ₹ 1.19 M
- Company Age 37 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.87 Cr
- Revenue Growth 70.93%
- Profit Growth 104.24%
- Ebitda 182.34%
- Net Worth 123.01%
- Total Assets 65.70%
About Mcneil And Argus Pharmaceuticals
Mcneil And Argus Pharmaceuticals Limited (MAAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 March 1988 and has a history of 37 years and one month. Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.10 M and a paid-up capital of Rs 1.19 M.
The company currently has active open charges totaling ₹4.87 Cr.
Renu Chhibber, Pawan Chhibber, and Gurdev Chhibber serve as directors at the Company.
Company Details
- Location
Ambala, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231HR1988PLC030217
- Company No.
030217
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Mcneil And Argus Pharmaceuticals Limited
Explore comprehensive data for Mcneil And Argus Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Mcneil And Argus Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurdev Chhibber  | Managing Director | 10-Mar-1988 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renu Chhibber | Whole-Time Director | 11-Nov-1994 | Current |
| Pawan Chhibber | Whole-Time Director | 18-Jul-2005 | Current |
Financial Performance of Mcneil And Argus Pharmaceuticals.
Mcneil And Argus Pharmaceuticals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 70.93% increase. The company also saw a substantial improvement in profitability, with a 104.24% increase in profit. The company's net worth Soared by an impressive increase of 123.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mcneil And Argus Pharmaceuticals?
In 2020, Mcneil And Argus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹48.70 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 4.87 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | Others | ₹4.87 Cr | Open |
How Many Employees Work at Mcneil And Argus Pharmaceuticals?
Unlock and access historical data on people associated with Mcneil And Argus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mcneil And Argus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mcneil And Argus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mcneil And Argus Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Mcneil And Argus Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Mcneil And Argus Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 48.70 M with Charge ID 100897433 was registered on 27 Mar 2024.
- Director Appointment
Pawan Chhibber was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 18 Jul 2005 & has been associated with this company since 19 years 9 months .
- Director Appointment
Renu Chhibber was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 11 Nov 1994 & has been associated with this company since 30 years 5 months .
- Director Appointment
Gurdev Dutt Chhibber was appointed as a Managing Director was appointed as a Managing Director on 10 Mar 1988 & has been associated with this company since 37 years 1 month .
Frequently asked questions
What is the Incorporation or founding date of Mcneil And Argus Pharmaceuticals Limited?
Mcneil And Argus Pharmaceuticals Limited was incorporated on 10 Mar 1988.
What is authorized share capital and paid-up capital of Mcneil And Argus Pharmaceuticals Limited?
The authorized share capital of Mcneil And Argus Pharmaceuticals Limited is ₹ 3.10 M and paid-up capital is ₹ 1.19 M.
Who are the current board members & directors of Mcneil And Argus Pharmaceuticals Limited?
Currently 3 directors are associated with Mcneil And Argus Pharmaceuticals Limited.
- Renu Chhibber
- Pawan Chhibber
- Gurdev Dutt Chhibber
What is the registered address of Mcneil And Argus Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mcneil And Argus Pharmaceuticals Limited is 100Rampur Sareri Road Ambalacantt.Ambala. India, Haryana, 133001.
What is the corporate identification number (CIN) and company number of Mcneil And Argus Pharmaceuticals Limited?
The corporate identification number (CIN) of Mcneil And Argus Pharmaceuticals Limited is U24231HR1988PLC030217 and the company number is 030217 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mcneil And Argus Pharmaceuticals Limited?
The Official website of Mcneil And Argus Pharmaceuticals Limited is https://www.mcneilargusindia.com
What has been the recent revenue trend for Mcneil And Argus Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2021, the revenue trend for Mcneil And Argus Pharmaceuticals Limited has risen by 70.93%.
What change has been observed in the net worth of Mcneil And Argus Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2021 indicates that The net worth of Mcneil And Argus Pharmaceuticals Limited has experienced an upsurge of 123.01%.
What are the total open charges for Mcneil And Argus Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2021, The total open charges for Mcneil And Argus Pharmaceuticals Limited amount to ₹ 4.87 Cr.
When was the last Balance Sheet of Mcneil And Argus Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Mcneil And Argus Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records